Neuropeptide SF (human)

Neuropeptide SF human augments paraventricular corticotrophin-releasing hormone (CRH) release and increases adrenocorticotropic hormone (ACTH) and corticosterone levels in the plasma. Neuropeptide SF human play a physiologic role in the regulation of such circadian functions as the activity of motor centers and the HPA axis, through the release of CRH[1].

Product Specifications

CAS Number

[192387-39-6]

Product Name Alternative

Neuropeptide NPFF (human)

UNSPSC

12352209

Target

CRFR

Type

Peptides

Related Pathways

GPCR/G Protein

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/neuropeptide-sf-human.html

Purity

99.53

Solubility

DMSO : 25 mg/mL (ultrasonic)

Smiles

O=C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CC(C)C)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](CCC(N)=O)C(N3[C@@H](CCC3)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC4=CC=CC=C4)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CO)N

Molecular Formula

C65H94N18O15

Molecular Weight

1367.55

References & Citations

[1]Jászberényi M, et al., The actions of neuropeptide SF on the hypothalamic-pituitary-adrenal axis and behavior in rats. Regul Pept. 2014 Jan 10;188:46-51.